Top Suppliers:I want be here
Related CAS#:
326866-17-5 855998-46-8
1033836-12-2 2135696-72-7
1150701-66-8 2632-13-5
2242109-74-4 2234285-81-3
1338545-01-9 1022150-12-4
1158522-08-7 940364-43-2
134104-43-1 131615-57-1
6906-52-1 930439-75-1
2228500-77-2 2227836-88-4
1018584-77-4 1375289-11-4

326866-17-5

326866-17-5 structure
326866-17-5 structure
  • Name: FAAH inhibitor 1
  • Chemical Name: N-[4-(6-Methyl-1,3-benzothiazol-2-yl)phenyl]-1-(2-thienylsulfonyl )-4-piperidinecarboxamide
  • CAS Number: 326866-17-5
  • Molecular Formula: C24H23N3O3S3
  • Molecular Weight: 497.65300
  • Catalog: Signaling Pathways Metabolic Enzyme/Protease FAAH
  • Create Date: 2017-02-14 01:22:59
  • Modify Date: 2024-01-11 20:43:58
  • FAAH inhibitor 1 is a potent fatty acid amide hydrolase (FAAH) inhibitor with an IC50 of 18±8 nM.IC50 Value: 18±8 nM [1]Target: FAAHTime-dependent preincubation study of FAAH inhibitor 1 was consistent with it being a reversible inhibitor. Activity-based protein-profiling (ABPP) evaluation of FAAH inhibitors 1 in rat tissues revealed that it had exceptional selectivity and no off-target activity with respect to other serine hydrolases. Molecular shape overlay of FAAH inhibitor 1 with a known FAAH inhibitor indicated that these compounds might act as transitionstate analogues, forming putative hydrogen bonds with catalytic residues and mimicking the charge distribution of the tetrahedral transition state. FAAH inhibitors 1 was exclusively specific against FAAH in rat brain and had no missing protein bands in all the other tissues that were tested [1].
Name N-[4-(6-Methyl-1,3-benzothiazol-2-yl)phenyl]-1-(2-thienylsulfonyl )-4-piperidinecarboxamide
Synonyms FAAH inhibitor 1
Description FAAH inhibitor 1 is a potent fatty acid amide hydrolase (FAAH) inhibitor with an IC50 of 18±8 nM.IC50 Value: 18±8 nM [1]Target: FAAHTime-dependent preincubation study of FAAH inhibitor 1 was consistent with it being a reversible inhibitor. Activity-based protein-profiling (ABPP) evaluation of FAAH inhibitors 1 in rat tissues revealed that it had exceptional selectivity and no off-target activity with respect to other serine hydrolases. Molecular shape overlay of FAAH inhibitor 1 with a known FAAH inhibitor indicated that these compounds might act as transitionstate analogues, forming putative hydrogen bonds with catalytic residues and mimicking the charge distribution of the tetrahedral transition state. FAAH inhibitors 1 was exclusively specific against FAAH in rat brain and had no missing protein bands in all the other tissues that were tested [1].
Related Catalog
References

[1]. Wang, Xueqing; Sarris, Katerina; Kage, Karen; et al. Synthesis and Evaluation of Benzothiazole-Based Analogues as Novel, Potent, and Selective Fatty Acid Amide Hydrolase Inhibitors. Journal of Medicinal Chemistry (2009), 52(1), 170-180.

[2]. Meyers, Marvin J.; Long, Scott A.; Pelc, Matthew J.; et al. Discovery of novel spirocyclic inhibitors of fatty acid amide hydrolase (FAAH). Part 1: Identification of 7-azaspiro[3.5]nonane and 1-oxa-8-azaspiro[4.5]decane as lead scaffolds. Bioorganic & Med
Molecular Formula C24H23N3O3S3
Molecular Weight 497.65300
Exact Mass 497.09000
PSA 144.23000
LogP 6.46430
Storage condition 2-8℃

Chemsrc provides CAS#:326866-17-5 MSDS, density, melting point, boiling point, structure, formula, molecular weight, synthetic route, etc.
title: CAS No. 326866-17-5 | Chemsrc address: https://www.chemsrc.com/en/baike/347404.html

Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer

Copyright © 2024 ChemSrc All Rights Reserved